Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020
Cites research funded by
1
ANTIGONE
1
EMPERIE
1
FP7_REST_ALL (Special project, May 2022)
1
FP7_REST_SecondPillar (Special project, May 2022)
1
National High-tech Research and Development Program
1
Youth Innovation Promotion Association of the Chinese Academy of Sciences
1
National Natural Science Foundation of China
1
Ministry of Science and Technology of the People's Republic of China
1
European Commission project PREPARE
1
Sakura Science Exchange Program
1
China Scholarship Council
1
Ministry of Education, Culture, Sports, Science and Technology
1
Core Research for Evolutional Science and Technology
1
Inamori Foundation
1
Japan Society for the Promotion of Science
1
Japan Agency for Medical Research and Development
Citations
Cited by 31 other policy documents
(26 of them are from other policy sources)
Everything cited by this document (explore the cited scholarly articles) (explore the cited policy documents)
New England Journal of Medicine (Massachusetts Medical Society)
Na Zhu et al. 2020
1) Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu, Peihua Niu, Faxian Zhan, Xuejun Ma, Dayan Wang, Wenbo Xu, Guizhen Wu, George F. Gao, Wenjie Tan, et al. A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med. 2020 Jan 24.
On
page 7
bioRxiv (Cold Spring Harbor Laboratory)
Alexander E. Gorbalenya et al. 2020
2) Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. Alexander E. Gorbalenya, Susan C. Baker, Ralph S. Baric, Raoul J. de Groot, Christian Drosten, Anastasia A. Gulyaeva, Bart L. Haagmans, Chris Lauber, Andrey M Leontovich, Benjamin W. Neuman, Dmitry Penzar, Stanley Perlman, Leo L.M. Poon, Dmitry Samborskiy, Igor A. Sidorov, Isabel Sola, John Ziebuhr. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv 2020.02.07.937862; doi: https://doi.org/10.1101/2020.02.07.937862
On
page 7
World Health Organization
4) Managing epidemics, key facts about major deadly diseases. Geneva: World Health Organization; 2018. (https://apps.who.int/iris/handle/10665/272 442).
On
page 7
World Health Organization
5) WHO Global Influenza Surveillance Network Manual for the laboratory diagnosis and virological surveillance of influenza, WHO, 2011 (https://www.who.int/influenza/gisrs_labor atory/manual_diagnosis_surveillance_influ enza/en/).
On
page 7
World Health Organization
6) Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases. Geneva: World Health Organization; 2018. (https://www.who.int/influenza/resources/p ublications/outbreak_investigation_protoco l/en/).
On
page 7
29) Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases. Geneva: World Health Organization; 2018. (https://www.who.int/influenza/resources/p ublications/outbreak_investigation_protoco l/en/).
On
page 9
World Health Organization
10) Global Surveillance for human infection with coronavirus disease (COVID-2019), Interim guidance, Geneva, World Health Organization, 2020. (https://www.who.int/publicationsdetail/global-surveillance-for-humaninfection-with-novel-coronavirus-(2019- ncov).
On
page 7
medRxiv (Cold Spring Harbor Laboratory)
Wei-jie Guan et al. 2020
12) Wei-jie Guan, Zheng-yi Ni, Yu Hu, Wen-hua Liang, Chun-quan Ou, Jian-xing He, Lei Liu, Hong Shan, Chun-liang Lei, David S.C. Hui, Bin Du, Lan-juan Li, Guang Zeng, Kwok-Yung Yuen, Ru-chong Chen, Chunli Tang, Tao Wang, Ping-yan Chen, Jie Xiang, Shi-yue Li 1, Jin-lin Wang, Zi-jing Liang, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian-ming Wang, Ji-yang Liu, M.D, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Nan-shan Zhong, Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint doi: https://doi.org/10.1101/2020.02.06.20020974.
On
page 8
Journal of Clinical Medicine (MDPI AG)
Natalie M. Linton et al. 2020
13) Nathalie M Linton, Tetsuro Kobayashi, Yichi Yang, Katsuma Hayashi, Andrei R. Akhmetzhanov, Sung-mok Jung, Baoyin Yuan, Ryo Kinoshita, Hiroshi Nishiura. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.J. Clin. Med. 2020, 9(2), 538; https://doi.org/10.3390/jcm9020538.
On
page 8
Emerging Microbes & Infections (Informa UK Limited)
Wei Zhang et al. 2020
15) Wei Zhang, Rong-Hui Du, Bei Li, Xiao-Shuang Zheng, Xing-Lou Yang, Ben Hu, Yan-Yi Wang, Geng-Fu Xiao, Bing Yan, Zheng-Li Shi & Peng Zhou (2020) Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerging Microbes & Infections, 9:1, 386-389 (https://www.tandfonline.com/doi/full/10.1 080/22221751.2020.1729071).
On
page 8
The American Journal of Gastroenterology (Ovid Technologies (Wolters Kluwer Health))
Xueying Shi et al. 2005
19) Shi X, Gong E, Gao D, et al. Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol. 2005;100 (1):169–176.
On
page 8
Science Advances (American Association for the Advancement of Science (AAAS))
Jie Zhou et al. 2017
20) Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv. 2017;3(11).
On
page 8
The Journal of Pathology (Wiley)
Yanqing Ding et al. 2004
21) Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J, Pathol. 2004;203(2):622–630.
On
page 8
World Health Organization
23) Guidance to minimize risks for facilities collecting, handling or storing materials potentially infectious for polioviruses (PIM Guidance). Geneva: World Health Organization;2018. http://polioeradication.org/wp- content/uploads/2016/07/PIM-guidance- 20190122-EN.pdf.
On
page 8
Virus Research (Elsevier BV)
Benjamin Meyer et al. 2014
24) Meyer B, Drosten C, Müller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014 Dec 19;194:175-83.
On
page 8
Journal of Medical Virology (Wiley)
Shu‐Yuan Xiao et al. 2020
26) Shu-Yuan Xiao, Yingjie Wu, Juan Li, Evolving status of the 2019 novel coronavirus infections: proposal of conventional serologic assays for disease diagnostics and infection monitoring. 2020, J Med Virol. 2020;1-4.
On
page 9